Type II NADH dehydrogenases as drug targets in Toxoplasma gondii

被引：0
|
作者：
Lin, S. S. [1 ]
Gross, U. [1 ]
Bohne, W. [1 ]
机构：
[1] Univ Med Gottingen, Inst Med Mikrobiol, Gottingen, Germany
来源：
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY | 2009年 / 299卷
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [31] A type II variant of Toxoplasma gondii infects the Eurasian otter (Lutra lutra) in southern Italy
    Viscardi, Maurizio
    Santoro, Mario
    Cozzolino, Loredana
    Borriello, Giorgia
    Fusco, Giovanna
    TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (02) : 874 - 880
  • [32] Diagnosis of congenital toxoplasmosis:: Comparison of targets for detection of Toxoplasma gondii by PCR
    Filisetti, D
    Gorcii, M
    Pernot-Marino, E
    Villard, O
    Candolfi, E
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (10) : 4826 - 4828
  • [33] Serotyping of Toxoplasma gondii in Cats (Felis domesticus) Reveals Predominance of Type II Infections in Germany
    Maksimov, Pavlo
    Zerweck, Johannes
    Dubey, Jitender P.
    Pantchev, Nikola
    Frey, Caroline F.
    Maksimov, Aline
    Reimer, Ulf
    Schutkowski, Mike
    Hosseininejad, Morteza
    Ziller, Mario
    Conraths, Franz J.
    Schares, Gereon
    PLOS ONE, 2013, 8 (11):
  • [34] Drivers of infection with Toxoplasma gondii genotype type II in Eurasian red squirrels (Sciurus vulgaris)
    Sara R. Wijburg
    Margriet G. E. Montizaan
    Marja J. L. Kik
    Maike Joeres
    Garance Cardron
    Christine Luttermann
    Miriam Maas
    Pavlo Maksimov
    Marieke Opsteegh
    Gereon Schares
    Parasites & Vectors, 17
  • [35] RHOMBOID ANTIGENS ARE PROMISING TARGETS IN THE VACCINE DEVELOPMENT AGAINST TOXOPLASMA GONDII
    Foroutan, Masoud
    Zaki, Leila
    Tavakoli, Sanaz
    Soltani, Shahrzad
    Taghipour, Ali
    Ghaffarifar, Fatemeh
    EXCLI JOURNAL, 2019, 18 : 259 - 272
  • [36] Type II topoisomerases as targets for rational drug design
    Laponogov, Ivan
    Veselkov, Dennis A.
    Umrekar, Trishant
    Crevel, Isabelle M-T.
    Pan, Xiao-Su
    Selvarajah, Jogitha
    Fisher, L. Mark
    Sanderson, Mark R.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S74 - S74
  • [37] Type II topoisomerases as targets for rational drug design
    Laponogov, I.
    Veselkov, D.
    Umrekar, T.
    Crevel, I.
    Pan, X.
    Fisher, L.
    Sanderson, M.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C713 - C713
  • [38] Toxoplasma gondii antibodies in type 1 Diabetes mellitus
    Goekce, Cumali
    Yazar, Sueleyman
    Bayram, Fahri
    Guendogan, Kursat
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2008, 28 (05): : 619 - 622
  • [39] Immobilization of the type XIV myosin complex in Toxoplasma gondii
    Johnson, Terezina M.
    Raifur, Zenon
    Jacobson, Ken
    Beckers, Con J.
    MOLECULAR BIOLOGY OF THE CELL, 2007, 18 (08) : 3039 - 3046
  • [40] The Toxoplasma gondii type-II NADH dehydrogenase TgNDH2-I is inhibited by 1-hydroxy-2-alkyl-4(1H)quinolones
    Lin, San San
    Kerscher, Stefan
    Saleh, Ahmad
    Brandt, Ulrich
    Gross, Uwe
    Bohne, Wolfgang
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2008, 1777 (11): : 1455 - 1462
12345